StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of Navidea Biopharmaceuticals stock opened at $0.05 on Friday. The business has a fifty day simple moving average of $0.06 […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Saturday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Up 2.0 % Shares of NAVB opened at $0.06 on Friday. Navidea Biopharmaceuticals has a 12-month low of $0.02 and a 12-month high […]
Stock analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.05 on Friday. The firm has a market cap of $5.39 […]
Analysts’ new coverage for Saturday, December 23rd: StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Ashford (NYSEAMERICAN:AINC). They issued a buy rating on the stock. StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM). StockNews.com issued a hold rating on […]
StockNews com Initiates Coverage on Navidea Biopharmaceuticals (NYSE:NAVB) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.